Publication | Closed Access

Cytotoxic effects of new trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolines and their interaction with antitumoral drugs gemcitabine and paclitaxel on cellular lines of human breast cancer

Cytotoxic EffectsNew Trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolinesBreast OncologyOncologyBiochemistryMedicineHuman Breast CancerBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyCancer Research